-
Something wrong with this record ?
The course of heart failure development and mortality in rats with volume overload due to aorto-caval fistula
Vojtech Melenovsky, Petra Skaroupkova, Jan Benes, VeraTorresova, Libor Kopkan, Ludek Cervenka
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NS10497
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Free Medical Journals
from 2010
ProQuest Central
from 1994-05-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2005-01-01
Health & Medicine (ProQuest)
from 1994-05-01 to 1 year ago
ROAD: Directory of Open Access Scholarly Resources
from 1996
PubMed
22116309
DOI
10.1159/000331562
Knihovny.cz E-resources
- MeSH
- Aorta, Abdominal abnormalities MeSH
- Arteriovenous Fistula complications mortality physiopathology MeSH
- Cardiomegaly etiology mortality physiopathology MeSH
- Rats MeSH
- Survival Rate trends MeSH
- Rats, Wistar MeSH
- Heart Failure etiology mortality physiopathology MeSH
- Vena Cava, Inferior abnormalities MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: There are only few studies documenting the long-term outcome of aorto-caval fistula (ACF) in rats, a model of volume overload heart failure (HF). The aim of the present study was to describe HF-related morbidity and mortality, and to examine the relation between cardiac hypertrophy and survival. METHODS: Adult male Wistar rats underwent needle ACF or sham operation and 71 animals surviving the acute procedure with patent ACF were followed for 52 weeks. RESULTS: By the end of the study, 72% of the ACF animals deceased and 82% developed HF signs. Of the HF rats, 65% died (median: 3 weeks after HF onset). Before death, body weight increased by 9% followed by a final drop. 28% ACF rats died suddenly, without preceding HF. Sudden death occurred earlier and in the rats with a trend to larger hearts (p = 0.07). In the whole ACF cohort, heart weight (heart weight/body weight ratio) was inversely associated with the length of survival (r = -0.51, p < 0.001). CONCLUSION: The median survival of ACF Wistar rats is 43 weeks, longer than reported in other rat strains. Increased heart weight is associated with higher mortality and a significant number of animals die suddenly.
Center for Cardiovascular Research Institute for Clinical and Experimental Medicine IKEM Prague
Department of Cardiology Institute for Clinical and Experimental Medicine IKEM Prague Czech Republic
Department of Physiology 2nd Faculty of Medicine Charles University Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012766
- 003
- CZ-PrNML
- 005
- 20180308091623.0
- 007
- ta
- 008
- 130404s2012 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000331562 $2 doi
- 035 __
- $a (PubMed)22116309
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Melenovský, Vojtěch $7 xx0160847 $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic
- 245 14
- $a The course of heart failure development and mortality in rats with volume overload due to aorto-caval fistula / $c Vojtech Melenovsky, Petra Skaroupkova, Jan Benes, VeraTorresova, Libor Kopkan, Ludek Cervenka
- 520 9_
- $a BACKGROUND: There are only few studies documenting the long-term outcome of aorto-caval fistula (ACF) in rats, a model of volume overload heart failure (HF). The aim of the present study was to describe HF-related morbidity and mortality, and to examine the relation between cardiac hypertrophy and survival. METHODS: Adult male Wistar rats underwent needle ACF or sham operation and 71 animals surviving the acute procedure with patent ACF were followed for 52 weeks. RESULTS: By the end of the study, 72% of the ACF animals deceased and 82% developed HF signs. Of the HF rats, 65% died (median: 3 weeks after HF onset). Before death, body weight increased by 9% followed by a final drop. 28% ACF rats died suddenly, without preceding HF. Sudden death occurred earlier and in the rats with a trend to larger hearts (p = 0.07). In the whole ACF cohort, heart weight (heart weight/body weight ratio) was inversely associated with the length of survival (r = -0.51, p < 0.001). CONCLUSION: The median survival of ACF Wistar rats is 43 weeks, longer than reported in other rat strains. Increased heart weight is associated with higher mortality and a significant number of animals die suddenly.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a aorta abdominalis $x abnormality $7 D001012
- 650 _2
- $a arteriovenózní píštěl $x komplikace $x mortalita $x patofyziologie $7 D001164
- 650 _2
- $a kardiomegalie $x etiologie $x mortalita $x patofyziologie $7 D006332
- 650 _2
- $a srdeční selhání $x etiologie $x mortalita $x patofyziologie $7 D006333
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a míra přežití $x trendy $7 D015996
- 650 _2
- $a vena cava inferior $x abnormality $7 D014682
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Škaroupková, Petra $7 xx0117683 $u Center for Cardiovascular Research, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Beneš, Jan, $d 1983- $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic $7 xx0221722
- 700 1_
- $a Torresová, Věra $u Center for Cardiovascular Research, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Kopkan, Libor $u Center for Cardiovascular Research, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Červenka, Luděk $u Department of Physiology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 35, č. 3 (2012), s. 167-173
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22116309 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20180308091625 $b ABA008
- 999 __
- $a ok $b bmc $g 975964 $s 811047
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 35 $c 3 $d 167-173 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
- GRA __
- $a NS10497 $p MZ0
- LZP __
- $a Pubmed-20130404